Capital International Investors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-124,831
Closed -$2.44M 481
2021
Q3
$2.44M Sell
124,831
-798,264
-86% -$30.4M ﹤0.01% 442
2021
Q2
$41.4M Buy
923,095
+262,847
+40% +$12.2M 0.01% 375
2021
Q1
$33.2M Buy
660,248
+507,940
+333% +$34.6M 0.01% 371
2020
Q4
$13.6M Sell
152,308
-96,404
-39% -$8.11M ﹤0.01% 400
2020
Q3
$19M Buy
+248,712
New +$15.8M 0.01% 375

Other funds holding CELL

Capital International Investors's CELL Position: Q4 2021 in Review

Capital International Investors sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 124,831 shares — an estimated $2.44M sold.

Capital International Investors first reported a position in CELL in Q3 2020 and held it in 5 quarters. The position peaked at $41.4M in Q2 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Capital International Investors reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Capital International Investors sold 124,831 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $2.44M.
  • Capital International Investors first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Capital International Investors's PhenomeX Inc. Common Stock position peaked at $41.4M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Capital International Investors's 13F filing for Q4 2021, filed 14 Feb 2022.